IN8Bio

1 follower


IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Employees

11-50

Links

Org chart

William Ho
Director, President, CEO & Co-Founder

William Ho

Collapse
Lawrence Lamb
EVP, Chief Scientific Officer & Co-Founder
Stacey Bilinski
Vice President Clinical Operations
Stacey Bilinski
VP, Clinical Operations